Samik Pharm. Co. Ltd agreed to acquire Hana 28 Special Purpose Acquisition Company (KOSDAQ:A454750) from T.S. Investment Corporation (KOSDAQ:A246690) and others in a reverse merger transaction for KRW 4.14 billion on May 13, 2025. The exchange ratio for the transaction is 0.280938. The transaction is subject to approval of offer by target shareholders. The expected completion of the transaction is September 30, 2025.

As of July 21, 2025, The general shareholders meeting is expected to take place on September 5, 2025. The new shares are expected to be listed on October 27, 2025.

The transaction is expected to close on October 13, 2025